Compound Testing in Scn1a+/- Dravet Mice

Project: Research project

Project Details

Description

A. Objective 1. To determine the effect and dose-response relationship of test compound treatment on hyperthermia-induced seizures in Scn1a+/- Dravet mice and wild-type littermates. B. Objective 2. To determine the effect and dose-response relationship of test compound treatment on general activity and anxiety measures in Scn1a+/- Dravet mice and wild-type littermates. A. Objective 1. To determine pharmacokinetics following oral administration of test compound in chow. B. Objective 2. To determine the effect and dose-dependence of test compound treatment on survival of Scn1a+/- Dravet mice. C. Objective 3. To determine the effect and dose-dependence of test compound treatment on spontaneous seizures in Scn1a+/- Dravet mice. D. Objective 4. To determine the effect of test compound treatment on spontaneous seizures and epileptiform activity in Scn1a+/- Dravet mice.
StatusFinished
Effective start/end date4/20/174/19/18

Funding

  • Ovid Therapeutics Inc. (IS00005188)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.